- Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis
-
Lee CW, Suh CW, Lee JS, Lee KH, Cho GY, Kim SW, Kim SH
- KMID: 644823
- J Korean Med Sci.
- 1994 Oct;9(5):369-375.
- doi: 10.3346/jkms.1994.9.5.369
To determine the contribution of metoclopramide to the efficacy of ondansetron in control of cisplatin-induced emesis, ondansetron was compared with ondansetron plus metoclopramide for antiemetic efficacy in a randomized double-blind... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting
-
Kim MS, Lee JR, Choi EM, Kim EH, Choi SH
- KMID: 2163638
- Yonsei Med J.
- 2015 Sep;56(5):1415-1420.
- doi: 10.3349/ymj.2015.56.5.1415
PURPOSE: Postoperative nausea and vomiting (PONV) is a common problem after general anesthesia. Although 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have significantly reduced PONV, over 35% of patients treated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of Antiemetics for the Prevention of Postoperative Nausea and Vomiting in High-Risk Patients
-
Kim EJ, Ko JS, Kim CS, Lee SM, Choi DH
- KMID: 1713297
- J Korean Med Sci.
- 2007 Oct;22(5):878-882.
- doi: 10.3346/jkms.2007.22.5.878
It was previously reported that the Korean predictive model could be used to identify patients at high risk of postoperative nausea and vomiting (PONV). This study investigated whether PONV in... -
- CITED
-
- Close
- SHARE
-
- Close
